Abstract
The present experiments were conducted to investigate effects of α-amino-3-hydroxy-5-methyl-4-isoxazoleprionic acid (AMPA)/kainate receptor blockade (CNQX, NBQX) on locomotor responses to D2/3 (7-OH-DPAT) and D1 [(+)-SKF 38393] dopamine receptor agonists in the nucleus accumbens (NAS) core and shell. CNQX (0.25–0.5 µg) microinjected into the NAS core or shell did not affect baseline locomotor activity. 7-OH-DPAT (2.5–5 µg) decreased locomotor activity. Co- administration of CNQX (0.5 µg) increased the effects of 7-OH-DPAT (5 µg) in the NAS core and shell. A similar increase was observed with NBQX (0.5 µg) in the NAS shell. (+)-SKF 38393 (5 µg) into the NAS core and shell increased locomotor activity after 30 min; this effect was not altered by CNQX (0.5 µg). As the D2/3 dopamine agonist (–)-quinpirole (2 µg) increased effects of (+)-SKF 38393 (5 µg) in NAS shell but not core, lack of site-selective effects of (+)-SKF-38393 and of 7-OH-DPAT within NAS is not attributable to drug diffusion. The previous observation that glutamate effects on locomotor activity depend on the relative involvement of D1 or D2/3 dopamine receptors in the NAS was based on the dopamine-depletion model. The present results demonstrate differential interactions of AMPA receptor blockade with dopamine agonists in ”dopamine-intact” animals.
Similar content being viewed by others
Author information
Authors and Affiliations
Additional information
Received: 21 November 1999 / Accepted: 10 January 2000
Rights and permissions
About this article
Cite this article
Choi, K., Zarandi, B., Todd, K. et al. Effects of AMPA/kainate receptor blockade on responses to dopamine receptor agonists in the core and shell of the rat nucleus accumbens. Psychopharmacology 150, 102–111 (2000). https://doi.org/10.1007/s002130000391
Issue Date:
DOI: https://doi.org/10.1007/s002130000391